Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001405152 | SCV001607069 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-09-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002332904 | SCV002628770 | uncertain significance | Inborn genetic diseases | 2018-10-21 | criteria provided, single submitter | clinical testing | The c.4392-5T>C intronic variant results from a T to C substitution 5 nucleotides upstream from coding exon 28 in the CACNA1A gene. This nucleotide position is poorly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this splice acceptor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |